Ghana to Host AHMTEC 2025, Pioneering Africa’s Healthcare Manufacturing Renaissance
Quidah is an online platform that connects investors with curated opportunities and expert insights on Africa’s emerging markets, while offering businesses promotional services, partnership facilitation, and market intelligence to attract capital and grow their operations.
Industries
Ghana is set to host the African Healthcare Manufacturing Trade Exhibition and Conference (AHMTEC) from 7th to 9th October 2025 at the Labadi Beach Hotel in Accra, marking a significant milestone in the continent’s quest for healthcare self-sufficiency. This pioneering event will bring together a diverse group of stakeholders including manufacturers, industry leaders, policymakers, investors, suppliers, and government officials from across Africa and beyond for a collaborative push toward strengthening local pharmaceutical manufacturing and healthcare supply chains.
The conference, themed “Collaborate to Compete: Strengthening Partnerships for Sustainable Growth,” aims to foster an environment where African manufacturers can expand their roles within the continent’s healthcare ecosystem by improving access to quality-assured medicines and health technologies. A central focus will be on equipping local firms to seize licensing opportunities and build robust regional networks that enable competitive production capabilities — a critical step toward reducing reliance on imports.
Prominent voices including Claudia Martínez, Director of Research at the Access to Medicine Foundation, will lead discussions on how licensing agreements between global pharmaceutical entities and African producers can serve mutual business and public health goals. Insights from these sessions will offer a blueprint for manufacturers aiming to integrate themselves into global supply chains while responding dynamically to Africa’s unique healthcare needs.
The event is also expected to spotlight investment readiness, with sessions tailored to preparing manufacturers to attract growth capital. Speakers will share key strategies on market positioning, financial robustness, and risk mitigation that are crucial for securing funding and scaling production capacities. This is particularly timely as Africa navigates its path toward industrialisation and economic independence through local value addition.
AHMTEC 2025 thus represents a critical platform for driving regional innovation, capacity building, and policy dialogue. It promises to accelerate progress toward a resilient, globally competitive African pharmaceutical industry capable of meeting the continent’s vast healthcare demands. By fostering collaboration among governments, private sector players, and international partners, the event embodies a shared vision of sustainable healthcare manufacturing that strengthens Africa’s health security and economic future.
Business and investment opportunities emerging from AHMTEC include pharmaceutical manufacturing, active pharmaceutical ingredient (API) production, supply chain enhancement, logistics, regulatory consulting, and technological innovation in health product development. Ancillary sectors such as workforce training, quality assurance services, and investment financing also stand to benefit substantially.
